Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-985-4 | CAS number: 68648-28-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- In vitro mamammlian cell gene mutation tests using the thymidine kinase gene" following OECD 490
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From April 11, 2017 to July 03, 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 490 (In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene)
- Version / remarks:
- OECD Guideline for the testing of chemicals, part 490, adopted July 26, 2016,”In vitro mammalian Cell gene mutation tests using the Thymidine Kinase Gene“
- Deviations:
- no
- Remarks:
- As all acceptability criteria of the assay were met or the deviations were considered as uncritical.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- EU-Method B.17 of the commission regulation (EC) no. 440/2008, adopted May 30, 2008,”In vitro mammalian Cell gene mutation test”
- Deviations:
- no
- Remarks:
- As all acceptability criteria of the assay were met or the deviations were considered as uncritical.
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- other: In vitro mamammlian cell gene mutation tests using the thymidine kinase gene
Test material
- Reference substance name:
- Linseed oil, ester with pentaerythritol
- EC Number:
- 271-985-4
- EC Name:
- Linseed oil, ester with pentaerythritol
- Cas Number:
- 68648-28-2
- Molecular formula:
- UVCB
- IUPAC Name:
- 2,3-dihydroxypropyl (7E,10E,13E)-hexadeca-7,10,13-trienoate; bis(3-[(7E,10E,13E)-hexadeca-7,10,13-trienoyloxy]-2-hydroxypropyl (9E)-octadec-9-enoate); 3-hydroxy-2-(hydroxymethyl)-2-[(octadec-9-enoyloxy)methyl]propyl (9E,12E,15E)-octadeca-9,12,15-trienoate; 3-hydroxy-2-{[(9E)-octadec-9-enoyloxy]methyl}-2-{[(9E,12E)-octadeca-9,12-dienoyloxy]methyl}propyl (9E,12E,15E)-octadeca-9,12,15-trienoate
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- Name: Linseed oil, ester with pentaerythritol
Batch no.: 16.343.096
Appearance: Yellow liquid
Composition: 100% UVCB
Purity: 100% as the substance is an UVCB
Homogeneity: Homogeneous
Expiry date: October 05, 2017
Storage Room Temperature:(20 ± 5°C), After opening keep under inert gas
Method
- Target gene:
- Thymidine kinase gene
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- The L5178Y is a murine T-cell lymphoma cell line, which grows as single or aggregated
round cells in suspension. This cell line is characterized by a high sensitivity to chemical
mutagens, by a high proliferation rate (doubling time 10-12 h in stock cultures), a high
cloning efficiency (CE) and a stable spontaneous mutant frequency. The L5178Y consists
of a stable karyotype and shows a diploid chromosome number (40 ± 2). The cells were
purchased by ATCC (Wesel, Germany) and were sold under the name L5178Y TK+/-
clone (3.7.2C) [TK+/- (clone 3.7.2C)] (ATCC® CRL-9518™). - Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- Liver enzyme S9 fraction/liver S9 mix from male rats, treated with Aroclor 1254
- Test concentrations with justification for top dose:
- Nominal concentrations in pre-test [μL/mL]: 5 2.5 1.25 0.63 0.31 0.16 0.08.
According to the OECD guideline 490 the highest concentration should be 0.01 M or 2 mg/mL or 2 μL/mL (whichever is lowest), unless limited by the solubility or toxicity of the test substance. RCE values below 20 % are considered toxic. In case of toxic effects, the highest test substance concentration of the main experiment should reduce the RSG value to 10 -20 %. In reference to the results of the pretest, 7-8 concentrations were chosen for experiment I and II:
Nominal concentrations in experiment I [μL/mL]: 2.5; 1.25; 0.63; 0.31; 0.16; 0.08; 0.04; 0.02
Nominal concentrations in experiment II [μL/mL]: 2.5; 0.63; 0.31; 0.16; 0.08; 0.04; 0.02 - Vehicle / solvent:
- In a non-GLP pre-test, the solubility of the test substance was determined. The test substance was sufficiently soluble in dimethyl sulfoxide (DMSO). Therefore, DMSO was used as solvent for the test substance.
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- RPMI 1640 medium without supplements was used as solvent control for the positive control methyl methanesulfonate (MMS). 0.9% NaCl was used as solvent control for the positive control cyclophosphamide (CPA). DMSO was used as solvent for the test item.
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- methylmethanesulfonate
- Remarks:
- (1) Methyl methanesulfonate (MMS) (-S9) 19.5 μg/mL (Experiment I) and 12.5 μg/mL (Experiment II). (2) Cyclophosphamide (CPA) monohydrate (+S9) 4.5 μg/mL
- Details on test system and experimental conditions:
- Method of application: Test substance in DMSO
Incubation period: 4 h (Experiment I) and 24 h (Experiment II)
Number of replications: Two replicates per culture: Experiment I with 8 concentrations + Experiment II with 7 concentrations
Determination of genotoxicity method: Relative total growth (RTG) % and mutant per 106 cells
The TK is able to catalyse the conversion of the purine analogue Trifluorothymidine (TFT) to its cytostatic and cytotoxic derivative trifluorothymidine-monophosphate. Therefore, cells deficient in TK are resistant to TFT. These cells are able to proliferate in the presence of the chemical substance whereas the non-mutated cells die. However, the mutant phenotype requires a certain period of time before it is completely expressed. The phenotypic expression is achieved by allowing exponential growth of the cells for 48 ± 4 h. The mutant frequency is determined by cloning a known number of cells in 96-well plates containing the selective agent to detect mutant cells, and in 96-well plates without selective agent to determine the number of surviving cells (cloning efficiency). After a suitable period of time the colonies are counted. Mutation frequencies are calculated from the number of mutant colonies (growth in selective medium) divided by the number of surviving cells (non-selective medium). Furthermore the size of the colonies is evaluated. Despite the exact genetic reason for the different colony forms is not yet clear, it was postulated many times, that the induction of large mutant colonies is generally associated with chemicals inducing single point mutations and the induction of small-colony mutants with chemicals inducing massive chromosomal aberrations (Schisler et al., 2013). In the pre-test the cytotoxicity of the cells is given by the relative cloning efficiency, RCE of the cells. In the case of a clear reduction of the RCE value in comparison to the solvent control a readjustment of the tested concentrations should be made for the main experiments. In the main experiments the cytotoxicity was determined by the more exactly but also more complex relative total growth (RTG). Generally, RTG and RCE values below 20 % were defined as cytotoxic (Moore et al., 2002). In this case a determination of the mutation frequency is not valid. Reference mutagens are tested in parallel to the test substance in order to demonstrate the sensitivity of the test system. - Rationale for test conditions:
- Reasons for the Choice of the Cell Line L5178Y
The L5178Y is a murine T-cell lymphoma cell line, which grows as single or aggregated round cells in suspension. This cell line is characterized by a high sensitivity to chemical mutagens, by a high proliferation rate (doubling time 10-12 h in stock cultures), a high cloning efficiency (CE) and a stable spontaneous mutant frequency. The L5178Y consists of a stable karyotype and shows a diploid chromosome number (40 ± 2). - Evaluation criteria:
- Cell Numbers for Determination of RSG
- Cell numbers in suspension were determined with a cell counter. Afterwards, the total suspension growth (TSG) and the relative suspension growth (RSG) was calculated
Viability
- Number of empty wells per microwell plate was counted manually. All generated data of each experiment (test item, solvent controls and positive control) were recorded in the raw data. Afterwards the relative cloning efficiency (RCE) and the relative total growth (RTG) were calculated
Mutant Colonies
Colonies were counted manually under a binocular magnifying glass. In accordance with their size, the colonies were classified into two groups:
- Less than 25 % of the well’s diameter = small colony
- More than 25 % of the well’s diameter = large colony
All generated data of each experiment (test item, solvent controls and positive control) were recorded in the raw data. Afterwards the mutant frequency (MF) was calculated - Statistics:
- A linear regression (least squares) of the test substance concentrations was performed to assess a possible dose dependent increase of mutant frequencies. With the assessment of this regression, it can be evaluated whether mutations increase with increasing dose of the test substance. A p-value of 0.05 or lower (significance level 95%) is considered as critical. No significant correlation between the test substance concentrations and the mutant frequency was detected. The positive controls were tested at one concentration only. Therefore, no dose depend- ency could be evaluated, although the positive controls showed considerable increases in mutants. In the following table, the statistical significance values are presented. The chi- square test was used. Statistically significant increase in mutants is considered as given if p is below 0.01.
Results and discussion
Test results
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Cytotoxicty was observed for 0.63 and 2.5 μL/mL test substance concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- Deviations from the study plan and guideline
In experiment I -S9, the TSG value in replicate B of the solvent control DMSO was 6.84% and therefore below 8%. The deviation is classified as uncritical, since it can be excluded that the end result is affected due to the slightly reduced growth rate in experiment I. In addition the mean of the two replicates was above 8. The deviation was assessed and signed by the study director on July 06, 2017.
In all experiments the RTG values of the cytotoxic test substance concentrations were not exactly between 10% and 20%. This deviation was considered as uncritical, since more important than a RTG value between 10-20% is, that a cytotoxic concentration occurs. In most cases, there is a point of turnover from complete cytotoxicity to low/moderate cytotoxicity. Therefore, a setting of such an exact RTG value is sometimes technically not possible. The deviation was assessed and signed by the study director on July 18, 2017.
Applicant's summary and conclusion
- Conclusions:
- Under the study conditions, the test substance did not induce mutations in the mouse lymphoma thymidine kinase locus assay using the cell line L5178Y in the absence and presence of metabolic activation. Therefore, the test substance is considered to be nonmutagenic under the conditions of the mouse lymphoma assay.
- Executive summary:
A study was conducted to determine the genotoxic potential of the test substance, Linseed oil, ester with pentaerythritol, with the in vitro mammalian cell gene mutation tests using the thymidine kinase gene according to OECD Guideline 490, in compliance with GLP. This study was performed to investigate the potential of the test substance to induce mutations at the thymidine kinase locus (Tk1) on chromosome 11 and/or structural chromosomal aberrations in mouse lymphoma L5178Y Tk+/- cells. The assay was performed in a pre-test and three independent experiments whereby the first experiment I was declared invalid and was repeated with different concentrations. The results of the invalid experiment are not included in this final report. The pre-test was performed to detect a potential cytotoxic effect of the test substance. Based on the results of this test the concentrations for the two main experiments were determined. Experiment I was performed with and without metabolic activation (liver enzyme S9 fraction / “liver S9 mix from male rats, treated with Aroclor 1254”) and a treatment period of 4 h. Experiment II was performed with a treatment period of 24 h in the absence of metabolic activation. The highest nominal tested concentration was 2.5 μL/mL. Turbidity of the test substance was visible in all experimental parts at the test substance concentrations 2.5 μL/mL, 1.25 μL/mL, 0.63 μL/mL and 0.31 μL/mL. For that reason, in accordance to the OECD 490, the highest analyzable test substance concentration for mutagenicity is 0.31 μL/mL. Appropriate reference mutagens were used as positive controls and showed a distinct increase in induced mutant colonies, indicating that the tests were sensitive and valid. No substantial and reproducible dose dependent increase in mutant colony numbers was observed in both experiments. No relevant shift of the ratio of small versus large colonies was observed up to the maximum concentration of the test substance. Under the study conditions, the test substance did not induce mutations in the mouse lymphoma thymidine kinase locus assay using the cell line L5178Y in the absence and presence of metabolic activation. Therefore, the test substance is considered to be nonmutagenic under the conditions of the mouse lymphoma assay (Fruhmesser, 2017).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.